Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Pediatric Rheumatology Online Journal |